XML 12 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Cover Page - USD ($)
 12 Months Ended
Feb. 01, 2025
Mar. 14, 2025
Aug. 02, 2024
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Feb. 01, 2025    
Document Transition Report false    
Entity File Number 1-3083    
Entity Registrant Name Genesco Inc    
Entity Incorporation, State or Country Code TN    
Entity Tax Identification Number 62-0211340    
Entity Address, Address Line One 535 Marriott Drive    
Entity Address, City or Town Nashville    
Entity Address, State or Province TN    
Entity Address, Postal Zip Code 37214    
City Area Code 615    
Local Phone Number 367-7000    
Title of 12(b) Security Common Stock, $1.00 par value    
Trading Symbol GCO    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction Flag false    
Entity Shell Company false    
Entity Public Float     $ 309,000,000
Entity Common Stock Shares Outstanding   11,038,311  
Entity Central Index Key 0000018498    
Amendment Flag false    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Current Fiscal Year End Date --02-01    
Documents Incorporated by Reference

Certain portions of registrant’s Definitive Proxy Statement for its 2025 Annual Meeting of Shareholders (which is expected to be filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended February 1, 2025) are incorporated by reference into Part III of this Annual Report on Form 10-K.

    
Auditor Name Ernst & Young LLP    
Auditor Location Nashville, Tennessee    
Auditor Firm ID 42    
Auditor Opinion [Text Block]

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Genesco Inc. (the Company) as of February 1, 2025 and February 3, 2024, the related consolidated statements of operations, comprehensive income (loss), cash flows, and equity for each of the three fiscal years in the period ended February 1, 2025, and the related notes and financial statement schedule listed in the Index at Item 15 (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at February 1, 2025 and February 3, 2024, and the results of its operations and its cash flows for each of the three years in the period ended February 1, 2025, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of February 1, 2025, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated March 26, 2025 expressed an unqualified opinion thereon.